Zimmer Biomet Holdings (ZBH) has risen sharply, recording gains of 3.13% in the past 4 weeks. However, the stock has corrected -1.57% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 2.07% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
The stock has recorded a 20-day Moving Average of 1.17% and the 50-Day Moving Average is 5.01%. Zimmer Biomet Holdings (NYSE:ZBH): On Fridays trading session , Opening price of the stock was $129.61 with an intraday high of $129.98. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $128.76. However, the stock managed to close at $129.34, a loss of 0.12% for the day. On the previous day, the stock had closed at $129.5. The total traded volume of the day was 867,195 shares.
The company Insiders own 1.22% of Zimmer Biomet Holdings shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -56.85% . Institutional Investors own 89.54% of Zimmer Biomet Holdings shares. During last six month period, the net percent change held by insiders has seen a change of -66.61%. Also, SunTrust Robinson Humphrey initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) In a research note issued to the investors, the brokerage major announces price-target of $155 per share.The shares have been rated Buy. The rating by the firm was issued on August 11, 2016.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.